Trial outcome prediction on Phase 2
0.629Log LossDataset Benchmark
Evaluation results
| Method | Links | |||
|---|---|---|---|---|
| Dataset BenchmarkTrial Phase=22025.11 | 0.629 | 0.218 | 6,200 | |
| BioBERT-based modelTrial Phase=22025.11 | 0.956 | 0.238 | — | |
| Industry BenchmarkTrial Phase=22025.11 | 1.034 | 0.408 | 7,100 |